Brooks Laboratories Q3 Results
- BSE: 533543
- NSE: BROOKS
- ISIN: INE650L01011
- Sector: Major Drugs
BSE
65.94
1.72 (2.68%)
1.72 (2.68%)Volume1.16 K
Updated: Fri 4 Sep, 2026 | 15:16:51
NSE
661.85 (2.88%)
1.85 (2.88%)Volume12.92 K
Updated: Fri 4 Sep, 2026 | 15:28:01
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Brooks Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 16.23 | 19.71 | -23.89% | 21.09 | -16.02% |
| Depreciation/ Amortization | 0.39 | 0.43 | 0.13% | 0.43 | 2.37% |
| Operating Income | 0.34 | 1.08 | -84.08% | 0.66 | -71.57% |
| Net Income | 5.50 | -3.96 | -31.07% | -3.88 | 0.00% |
| Other Operating Expenses Total | 3.12 | 2.87 | -5.13% | 2.35 | 8.12% |
| Net Income Before Taxes | 5.50 | -3.96 | -31.07% | -3.85 | 0.00% |
| Total Revenue | 16.57 | 20.79 | -29.36% | 21.75 | -19.25% |
| Selling/ General/ Admin Expenses Total | 3.72 | 3.21 | -5.41% | 2.84 | 12.79% |
| Diluted Normalized EPS | 1.87 | -1.51 | -31.00% | -1.51 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.